{"prompt": "['18.', 'Begbie ME, Wallace GM, Shovlin CL. Hereditary haemorrhagic telangiectasia (Osler-', 'Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. Jan', '2003;79(927):18-24.', '19.', 'Buscarini E, Danesino C, Olivieri C, et al. Doppler ultrasonographic grading of hepatic', 'vascular malformations in hereditary hemorrhagic telangiectasia -- results of extensive', 'screening. Ultraschall Med. Sep 2004;25(5):348-355.', '20.', 'Buscarini E, Plauchu H, Garcia Tsao G, et al. Liver involvement in hereditary', 'hemorrhagic telangiectasia: consensus recommendations. Liver Int. Nov', '2006;26(9):1040-1046.', '21.', 'Bauer T, Britton P, Lomas D, Wight DG, Friend PJ, Alexander GJ. Liver transplantation', 'for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia. J', 'Hepatol. May 1995;22(5):586-590.', '22.', 'Boillot O, Bianco F, Viale JP, et al. Liver transplantation resolves the hyperdynamic', 'circulation in hereditary hemorrhagic telangiectasia with hepatic involvement.', 'Gastroenterology. Jan 1999;116(1):187-192.', '23.', 'Azoulay D, Precetti S, Emile JF, et al. [Liver transplantation for intrahepatic Rendu-', \"Osler-Weber's disease: the Paul Brousse hospital experience]. Gastroenterol Clin Biol.\", 'Oct 2002;26(10):828-834.', '24.', 'Lerut J, Orlando G, Adam R, et al. Liver transplantation for hereditary hemorrhagic', 'telangiectasia: Report of the European liver transplant registry. Ann Surg. Dec', '00;244(6):854-862; discussion 862-854.', '25.', 'Babin E, Borsik M, Braccard S, et al. [Treatments of hereditary hemorrhagic', 'telangiectasia of the nasal mucosa]. Rev Laryngol Otol Rhinol (Bord). 2005;126(1):43-', '48.', '26.', 'Yin LX, Reh DD, Hoag JB, et al. The minimal important difference of the epistaxis', 'severity score in hereditary hemorrhagic telangiectasia. Laryngoscope. May', '2016;126(5):1029-1032.', '27.', 'Gaillard S, Dupuis-Girod S, Boutitie F, et al. Tranexamic acid for epistaxis in hereditary', 'hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare', 'disease. J Thromb Haemost. Sep 2014;12(9):1494-1502.', '28.', 'David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in', 'angiogenesis. Cytokine Growth Factor Rev. Jun 2009;20(3):203-212.', '29.', 'David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10', 'as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in', 'endothelial cells. Blood. Mar 1 2007;109(5):1953-1961', '30.', 'David L, Mallet C, Keramidas M, et al. Bone morphogenetic protein-9 is a circulating', 'vascular quiescence factor. Circ Res. Apr 25 2008;102(8):914-922.', '31.', 'Bailly S, Dupuis-Girod S, Plauchu H. [Rendu-Osler disease: clinical and molecular', 'update]. Med Sci (Paris). Oct 2010;26(10):855-860.', '32.', 'Oh SP, Seki T, Goss KA, et al. Activin receptor-like kinase 1 modulates transforming', 'growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U', 'S A. Mar 14 2000;97(6):2626-2631.', '33.', 'Tual-Chalot S, Mahmoud M, Allinson KR, et al. Endothelial depletion of Acvrl1 in mice', 'leads to arteriovenous malformations associated with reduced endoglin expression.', 'PloS one. 2014;9(6):e98646.', '34.', 'Park SO, Wankhede M, Lee YJ, et al. Real-time imaging of de novo arteriovenous', 'malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest.', 'Nov 2009;119(11):3487-3496.', '35.', 'Spiekerkoetter E, Tian X, Cai J, et al. FK506 activates BMPR2, rescues endothelial', 'dysfunction, and reverses pulmonary hypertension.', 'Clin', 'Invest.', 'Aug', '2013;123(8):3600-3613', '36.', 'SPC Protopic 0.1% ointment. 2015. https://www.medicines.org.uk/emc/medicine/8816', '37.', 'Kelly PA, Burckart GJ, Venkataramanan R. Tacrolimus: a new immunosuppressive', 'agent. American journal of health-system pharmacy : AJHP : official journal of the', 'American Society of Health-System Pharmacists. Jul 15 1995;52(14):1521-1535.', 'Page 58 of 64']['38.', 'Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of', 'tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation:', 'decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant.', 'Apr 1999;18(4):336-345.', '39.', 'Alomar A, Puig L, Gallardo CM, Valenzuela N. Topical tacrolimus 0.1% ointment', '(protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar', 'degree to mometasone furoate 0.1% with greater suppression of late erythema.', 'Contact dermatitis. Oct 2003;49(4):185-188', '40.', 'Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment', '(Protopic). The Journal of dermatological treatment. 003;14(Suppl 1):5-16.', '41.', 'Arana A, Wentworth CE, Fernandez-Vidaurre C, Schlienger RG, Conde E, Arellano', 'FM. Incidence of cancer in the general population and in patients with or without atopic', 'dermatitis in the U.K. Br J Dermatol. Nov 2010;163(5):1036-1043.', '42.', 'Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M. Association between', 'exposure to topical tacrolimus or pimecrolimus and cancers. The Annals of', 'pharmacotherapy. Dec 2009;43(12):1956-1963', '43.', 'Schneeweiss S, Doherty M, Zhu S, et al. Topical treatments with pimecrolimus,', 'tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.', 'Dermatology. 2009;219(1):7-21.', '44.', 'Tan J, Langley R. Safety and efficacy of tacrolimus ointment 0.1% (Protopic) in atopic', 'dermatitis: a Canadian open-label multicenter study. Journal of cutaneous medicine', 'and surgery. Jul-Aug 2004;8(4):213-219', '45.', 'Siegfried EC, Jaworski JC, Kaiser JD, Hebert AA. Systematic review of published trials:', 'long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric', 'patients with atopic dermatitis. BMC pediatrics. Jun 07 2016;16:75.', '46.', 'Liao YH, Chiu HC, Tseng YS, Tsai TF. Comparison of cutaneous tolerance and efficacy', 'of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic', 'plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized', 'controlled trial. Br J Dermatol. Nov 2007;157(5):1005-1012.', '47.', 'Corrocher G, Di Lorenzo G, Martinelli N, et al. Comparative effect of tacrolimus 0.1%', 'ointment and clobetasol 0.05% ointment in patients with oral lichen planus. Journal of', 'clinical periodontology. Mar 2008;35(3):244-249', '48.', 'Vohra S, Singal A, Sharma SB. Clinical and serological efficacy of topical calcineurin', 'inhibitors in oral lichen planus: a prospective randomized controlled trial. International', 'journal of dermatology. Jan 2016;55(1):101-105.', '49.', 'Arduino PG, Carbone M, Della Ferrera F, et al. Pimecrolimus vs. tacrolimus for the', 'topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized', 'double-blind controlled study. Journal of the European Academy of Dermatology and', 'Venereology : JEADV. Apr 2014;28(4):475-482.', '50.', 'Sonthalia S, Singal A. Comparative efficacy of tacrolimus 0.1% ointment and clobetasol', 'propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial.', 'International journal of dermatology. Nov 2012;51(11):1371-13', '51.', 'Barot RK, Shitole SC, Bhagat N, Patil D, Sawant P, Patil K. Therapeutic effect of 0.1%', 'Tacrolimus Eye Ointment in Allergic Ocular Diseases. Journal of clinical and diagnostic', 'research : JCDR. Jun 2016;10(6):NC05-09.', '52.', 'Fukushima A, Ohashi Y, Ebihara N, et al. Therapeutic effects of 0.1% tacrolimus eye', 'drops for refractory allergic ocular diseases with proliferative lesion or corneal', 'involvement. Br J Ophthalmol. Aug 2014;98(8):1023-1027', '53.', 'Chatterjee S, Agrawal D. Tacrolimus in Corticosteroid-Refractory Vernal', 'Keratoconjunctivitis. Cornea. Nov 2016;35(11):1444-144', '54.', 'Shoughy SS, Jaroudi MO, Tabbara KF. Efficacy and safety of low-dose topical', 'tacrolimus in vernal keratoconjunctivitis. Clin Ophthalmol. 016;10:643-647.', '55.', 'Reitamo S, Mandelin J, Rubins A, et al. The pharmacokinetics of tacrolimus after first', 'and repeated dosing with 0.03% ointment in infants with atopic dermatitis. International', 'journal of dermatology. Apr 2009;48(4):348-355.', 'Page 59 of 64']\n\n###\n\n", "completion": "END"}